AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.

Research / 22 October 2024

Pharmacovigilance monitors the safety of the medicines we use, but what about those that get into our environment?

In focus / 15 October 2024

The READUS-PV statement is the first-ever guide for reporting disproportionality analyses that are replicable, reliable, and reproducible.

Research / 07 October 2024

How does an economics theory apply to drug safety, and how can we use it to better manage rare, unexpected, and serious adverse drug reactions?

Perspective / 23 September 2024